Creative Planning - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.

Quarter-by-quarter ownership
Creative Planning ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2019$242,000
+112.3%
21,0000.0%0.00%
Q3 2019$114,000
-52.1%
21,000
+5.0%
0.00%
-100.0%
Q2 2019$238,000
+126.7%
20,0000.0%0.00%
Q1 2019$105,000
+66.7%
20,0000.0%0.00%
Q4 2018$63,000
-55.0%
20,000
-13.3%
0.00%
-100.0%
Q3 2018$140,000
+15.7%
23,070
+0.9%
0.00%
Q2 2018$121,000
+61.3%
22,870
+76.8%
0.00%
Q1 2018$75,00012,9330.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2019
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders